Experts question continuation of Covishield vaccine trials in India despite adverse event report Read more
Success of indigenous COVID-19 vaccines will make access easy and affordable in India: GlobalData Read more
Serum Institute of India gets DCGI nod for phase 2 and 3 human trials of Oxford vaccine candidate Read more
COVID-19 panel recommends DCGI to permit SII to conduct human trials of Oxford vaccine candidate Read more